KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Capital Expenditures (2018 - 2026)

Castle Biosciences' Capital Expenditures history spans 8 years, with the latest figure at $7.2 million for Q4 2025.

  • On a quarterly basis, Capital Expenditures fell 5.06% to $7.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $36.0 million, a 27.17% increase, with the full-year FY2025 number at $36.0 million, up 27.17% from a year prior.
  • Capital Expenditures hit $7.2 million in Q4 2025 for Castle Biosciences, down from $22.0 million in the prior quarter.
  • Over the last five years, Capital Expenditures for CSTL hit a ceiling of $33.2 million in Q3 2021 and a floor of -$29.7 million in Q4 2021.
  • Historically, Capital Expenditures has averaged $3.7 million across 5 years, with a median of $1.8 million in 2024.
  • The widest YoY moves for Capital Expenditures: up 103590.62% in 2021, down 114334.62% in 2021.
  • Tracing CSTL's Capital Expenditures over 5 years: stood at -$29.7 million in 2021, then skyrocketed by 115.15% to $4.5 million in 2022, then plummeted by 120.04% to -$902000.0 in 2023, then soared by 938.91% to $7.6 million in 2024, then dropped by 5.06% to $7.2 million in 2025.
  • Business Quant data shows Capital Expenditures for CSTL at $7.2 million in Q4 2025, $22.0 million in Q3 2025, and $2.1 million in Q2 2025.